A molecular discovery platform leverages advanced technologies like synthetic libraries, hybridoma, Bispecific Antibody, single B cell sorting, and AI to identify and develop novel antibodies efficiently.
Our pilot R&D and production platform excels in small-scale processes and Fed-Batch culture, using advanced purification technologies like affinity and ion exchange chromatography. We produce high-purity antibody and protein solutions, and various drug products with industry-leading filling accuracy.
A quality control platform conducts comprehensive tests including molecular weight, sequence coverage, disulfide bond location, peptide mapping, N/C terminal sequencing, post-translational modifications, DAR value, and unknown peak identification.
